Revenue: The sum of all revenue fields included for a company's operating activities.
Oncolytics Biotech Inc. (ONCY) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-4.46M |
|
-- |
|
-- |
|
$4.13M |
|
$-4.13M |
|
$-0.27M |
|
$-4.40M |
|
$-4.40M |
|
$-4.46M |
|
$-4.46M |
|
$-4.46M |
|
$-4.46M |
|
$-4.13M |
|
$-4.05M |
|
91.00M |
|
91.00M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$13.66M |
|
$0.25M |
|
$0.78M |
|
$14.44M |
|
$4.74M |
|
-- |
|
$5.30M |
|
$10.04M |
|
$4.40M |
|
$4.40M |
|
$4.40M |
|
97.41M |
|
| Cash Flow Statement Financials | |
$-8.65M |
|
-- |
|
$8.14M |
|
$11.53M |
|
$10.57M |
|
$-0.95M |
|
$1.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-101.25% |
|
-101.25% |
|
-30.87% |
|
-101.25% |
|
$0.05 |
|
$-0.10 |
|
$-0.10 |
|